NCT06102785View on ClinicalTrials.gov

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

October 10, 2026

Study Completion Date

October 10, 2026

Conditions
Gastric Cancer
Interventions
DRUG

Fruquintinib, TAS102

Fruquintinib combined with TAS102

Trial Locations (1)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER